NCT01589653 Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Status COMPLETED Phase PHASE4
NCT01586936 Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors Status COMPLETED Phase N/A
NCT01585506 Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues Status COMPLETED Phase N/A
NCT01580605 French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin Status COMPLETED Phase N/A
NCT01579968 Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery Status COMPLETED Phase N/A
NCT01579955 Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice Status COMPLETED Phase N/A
NCT01578135 French National Registry of Children Born Small for Gestational Age Treated With Somatropin Status COMPLETED Phase N/A
NCT01572753 Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01572740 Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01570751 A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin Status COMPLETED Phase PHASE3
NCT01569841 A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT01566786 Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage Status COMPLETED Phase PHASE2
NCT01565733 Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes Status COMPLETED Phase N/A
NCT01565408 Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01564563 Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation Status TERMINATED Phase PHASE2
NCT01563926 Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency Status COMPLETED Phase PHASE3
NCT01563523 Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients Status COMPLETED Phase PHASE2
NCT01563471 Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01563458 Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation Status COMPLETED Phase PHASE2
NCT01563445 Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage Status COMPLETED Phase PHASE2